Cargando…

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Chang S., Laddha, Saurabh V., Lewis, Peter W., Koletsky, Matthew S., Robzyk, Kenneth, Da Silva, Edaise, Torres, Paula J., Untch, Brian R., Li, Janet, Bose, Promita, Chan, Timothy A., Klimstra, David S., Allis, C. David, Tang, Laura H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185985/
https://www.ncbi.nlm.nih.gov/pubmed/30315258
http://dx.doi.org/10.1038/s41467-018-06498-2
_version_ 1783362784599212032
author Chan, Chang S.
Laddha, Saurabh V.
Lewis, Peter W.
Koletsky, Matthew S.
Robzyk, Kenneth
Da Silva, Edaise
Torres, Paula J.
Untch, Brian R.
Li, Janet
Bose, Promita
Chan, Timothy A.
Klimstra, David S.
Allis, C. David
Tang, Laura H.
author_facet Chan, Chang S.
Laddha, Saurabh V.
Lewis, Peter W.
Koletsky, Matthew S.
Robzyk, Kenneth
Da Silva, Edaise
Torres, Paula J.
Untch, Brian R.
Li, Janet
Bose, Promita
Chan, Timothy A.
Klimstra, David S.
Allis, C. David
Tang, Laura H.
author_sort Chan, Chang S.
collection PubMed
description The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis to reveal two distinct subgroups with one consisting entirely of A-D-M mutant PanNETs. Two genes differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha-cells (FDR q-value < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells.
format Online
Article
Text
id pubmed-6185985
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61859852018-10-15 ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup Chan, Chang S. Laddha, Saurabh V. Lewis, Peter W. Koletsky, Matthew S. Robzyk, Kenneth Da Silva, Edaise Torres, Paula J. Untch, Brian R. Li, Janet Bose, Promita Chan, Timothy A. Klimstra, David S. Allis, C. David Tang, Laura H. Nat Commun Article The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis to reveal two distinct subgroups with one consisting entirely of A-D-M mutant PanNETs. Two genes differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha-cells (FDR q-value < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells. Nature Publishing Group UK 2018-10-12 /pmc/articles/PMC6185985/ /pubmed/30315258 http://dx.doi.org/10.1038/s41467-018-06498-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Chan, Chang S.
Laddha, Saurabh V.
Lewis, Peter W.
Koletsky, Matthew S.
Robzyk, Kenneth
Da Silva, Edaise
Torres, Paula J.
Untch, Brian R.
Li, Janet
Bose, Promita
Chan, Timothy A.
Klimstra, David S.
Allis, C. David
Tang, Laura H.
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title_full ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title_fullStr ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title_full_unstemmed ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title_short ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
title_sort atrx, daxx or men1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185985/
https://www.ncbi.nlm.nih.gov/pubmed/30315258
http://dx.doi.org/10.1038/s41467-018-06498-2
work_keys_str_mv AT chanchangs atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT laddhasaurabhv atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT lewispeterw atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT koletskymatthews atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT robzykkenneth atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT dasilvaedaise atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT torrespaulaj atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT untchbrianr atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT lijanet atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT bosepromita atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT chantimothya atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT klimstradavids atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT alliscdavid atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup
AT tanglaurah atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup